Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Corvus Pharmaceuticals Ownership Summary


Corvus Pharmaceuticals is owned by 10.57% institutional investors, 3.51% insiders, and 85.92% retail investors. Orbimed advisors is the largest institutional shareholder, holding 9.07% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.78% of its assets in Corvus Pharmaceuticals shares.

CRVS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCorvus Pharmaceuticals10.57%3.51%85.92%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors7.17M9.07%$104.82M
Blackrock funding, inc. /de6.16M7.80%$90.13M
Vanguard group3.87M4.68%$29.83M
State street3.57M4.52%$52.17M
Adams street partners3.28M4.15%$47.92M
Price t rowe associates inc /md/2.92M3.69%$42.68M
Vivo capital2.81M3.55%$41.05M
Morgan stanley2.50M3.16%$36.56M
Deep track capital, lp2.49M3.16%$36.45M
Wellington management group llp2.32M2.94%$33.92M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Adams street partners3.28M18.41%$47.92M
Foresite capital management vi1.83M5.82%$26.79M
Vivo capital2.81M3.43%$41.05M
Catalio capital management, lp891.93K2.73%$13.05M
Dcf advisers637.50K2.49%$9.33M
Blue owl capital lp545.00K2.14%$7.97M
Boxer capital management1.10M2.11%$16.09M
Orbimed advisors7.17M2.09%$104.82M
Commodore capital lp2.26M1.91%$33.05M
Bioimpact capital1.67M1.89%$24.50M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/2.92M0.00%2.88M
Deep track capital, lp2.49M0.60%2.49M
Commodore capital lp2.26M1.91%2.26M
Wellington management group llp2.32M0.01%2.00M
Braidwell lp1.75M0.86%1.75M

Top Sellers

HolderShares% AssetsChange
Samlyn capital---4.07M
Point72 asset management---2.88M
Morgan stanley2.50M0.00%-1.07M
Bioimpact capital1.67M1.89%-1.07M
Deerfield management company, l.p. (series c)---1.00M

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp2.49M0.60%2.49M$36.45M
Commodore capital lp2.26M1.91%2.26M$33.05M
Braidwell lp1.75M0.86%1.75M$25.64M
Hood river capital management1.34M0.20%1.34M$19.53M
Boxer capital management1.10M2.11%1.10M$16.09M

Sold Out

HolderChange
Srs capital advisors-10.00
Parallel advisors-20.00
Ifp advisors-24.00
Eversource wealth advisors-60.00
Kelleher financial advisors-75.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202664-51.88%8,345,679-82.12%100.33%43-39.44%14-53.33%
Dec 31, 202583-22.43%26,771,704-35.76%321.13%44-25.42%17-
Sep 30, 20251066.00%41,641,007-0.34%531.86%59-7.81%1721.43%
Jun 30, 202599-4.81%41,766,67815.16%532.12%6361.54%13-55.17%
Mar 31, 20251042.97%36,268,523-3.73%501.58%40-41.18%29190.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.34M2.78%-
State Street® SPDR® S&P® Biotech ETF2.33M2.77%-23.32K
Vanguard US Total Market Shares ETF1.58M2.32%-
iShares Russell 2000 ETF1.52M1.81%12.83K
Vanguard Institutional Extnd Mkt Idx Tr830.80K0.99%9.89K
Polar Capital Healthcare Opports Inc830.54K0.99%-
Hood River Small-Cap Growth Instl744.09K0.88%744.09K
US Small-Cap Growth II Equity Comp722.28K0.86%722.28K
T. Rowe Price New Horizons722.28K0.86%318.23K
MEDICAL BioHealth EUR Acc610.92K0.73%-128.28K

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026MILLER RICHARD A MD President and CEOBuy$60.25K
May 18, 2026MILLER RICHARD A MD President and CEOBuy$23.20K
Jun 27, 2025ORBIMED ADVISORS LLC Sell$4.89M
Jun 27, 2025Thompson Peter A. Sell$4.89M
May 06, 2024Thompson Peter A. Buy$4.89M

Insider Transactions Trends


DateBuySell
2026 Q22-
2026 Q1--
2025 Q4--
2025 Q2-2
2024 Q4--

CRVS Ownership FAQ


Who Owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals shareholders are primarily institutional investors at 10.57%, followed by 3.51% insiders and 85.92% retail investors. The average institutional ownership in Corvus Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Corvus Pharmaceuticals falls below.

Who owns the most shares of Corvus Pharmaceuticals?

Corvus Pharmaceuticals’s largest shareholders are Orbimed advisors (7.17M shares, 9.07%), Blackrock funding, inc. /de (6.16M shares, 7.80%), and Vanguard group (3.87M shares, 4.68%). Together, they hold 21.55% of Corvus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Corvus Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Corvus Pharmaceuticals.

Who is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Adams street partners is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 18.41% of its assets in 3.28M Corvus Pharmaceuticals shares, valued at 47.92M$.

Who is the top mutual fund holder of Corvus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Corvus Pharmaceuticals shares, with 2.78% of its total shares outstanding invested in 2.34M Corvus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools